LEVOFLOXACINE, powder, 1g (Sigma 28266-1G-F)
STD
SASTAPWDLVX1
Valid Article
Account code:
60200
HS Code:
382290
Last Updated on:
02/05/2024, 22:44:37
Former
Code(s):
SLASZFR0512
Single use
A single-use device, also referred to as a disposable device, is intended for use on one patient during a single procedure. It is not intended to be reprocessed (i.e., cleaned and disinfected or sterilized).
W0104010699 - Media for mycobacteria cultures - manual & automated (for ast drugs , supplements) - other
European Medical Device Nomenclature (EMDN) is the nomenclature of use by manufacturers when registering their medical devices in the EUDAMED database. EMDN is characterised by its alphanumeric structure that is established in a seven-level hierarchical tree.
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
LEVOFLOXACIN
Reserved for TB culture programmes
Definition
Antimycobacterial used for drug susceptibility testing of M. tuberculosis complex.
Specifications
Some restricted information has been hidden. Sign in
to see this information
Technical specifications
- Form: powder
- Color: white to faint yellow
- CAS Number: 100986-85-4
- Formula: C18H20FN3O4
- Formula Weight: 361.37 g/mol
- Purity: >=98.0 %
Packaging & Labelling
1 g vial
Instructions for use
- Always follow the Standard Operations Procedures for the preparation of the stock solution and the working solution.
- The drug working solution is added to the medium during preparation (agar or LJ) or prior to inoculation (MGIT broth tubes).
Storage
- Store in a cool place at room temperature.
- Keep container tightly closed in a dry and well-ventilated place.
- Avoid formation of dust and aerosols.
Waste management
Substance with biohazardous characteristics. Please contact your watsan referent for advice on proper disposal.
Detailed hazard and precautionary information can be found in the safety data sheet (SDS).
Classification EC Regulation N° 1272/2008
- Acute toxicity, Oral (Category 4)
- Respiratory sensitization (Category 1)
- Skin sensitization (Category 1)
- Reproductive toxicity (Category 2)
- Effects on or via lactation
Signal Word
Danger
| H302 | Harmful if swallowed |
| H317 | May cause an allergic skin reaction |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| H361 | Suspected of damaging fertility or the unborn child (route of exposure if it is conclusively proven that no other routes of exposure cause the hazard). |
| H362 | May cause harm to breast-fed children. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection |
| P342 + P311 | If experiencing respiratory symptoms: Call a POISON CENTER or |
MSF requirements
Reserved for TB culture programmes
Levofloxacin is part of the second line drugs used against M. tuberculosis complex. The test is performed to investigate resistance of the mycobacteria to this antibiotic. It can be used for liquid and solid cultures.
Some restricted information has been hidden. Sign in
to see this information